Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Navient Corporation is a credit services business based in the US. Navient Corporation shares (NAVI) are listed on the NASDAQ and all prices are listed in US Dollars. Navient Corporation employs 5,560 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$19.92|
|52-week range||$7.54 - $23.80|
|50-day moving average||$21.60|
|200-day moving average||$19.31|
|Wall St. target price||$21.45|
|Dividend yield||$0.64 (3.19%)|
|Earnings per share (TTM)||$5.10|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||-0.85%|
|1 month (2021-09-21)||-10.83%|
|3 months (2021-07-21)||-3.25%|
|6 months (2021-04-21)||32.53%|
|1 year (2020-10-21)||116.99%|
|2 years (2019-10-21)||66.56%|
|3 years (2018-10-19)||58.47%|
|5 years (2016-10-21)||52.88%|
Valuing Navient Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Navient Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Navient Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 4x. In other words, Navient Corporation shares trade at around 4x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Navient Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.142. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Navient Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$2.3 billion|
|Operating margin TTM||54.72%|
|Gross profit TTM||$1.5 billion|
|Return on assets TTM||1.09%|
|Return on equity TTM||39.19%|
|Market capitalisation||$3.4 billion|
TTM: trailing 12 months
There are currently 6.0 million Navient Corporation shares held short by investors – that's known as Navient Corporation's "short interest". This figure is 16.6% down from 7.2 million last month.
There are a few different ways that this level of interest in shorting Navient Corporation shares can be evaluated.
Navient Corporation's "short interest ratio" (SIR) is the quantity of Navient Corporation shares currently shorted divided by the average quantity of Navient Corporation shares traded daily (recently around 2.4 million). Navient Corporation's SIR currently stands at 2.49. In other words for every 100,000 Navient Corporation shares traded daily on the market, roughly 2490 shares are currently held short.
However Navient Corporation's short interest can also be evaluated against the total number of Navient Corporation shares, or, against the total number of tradable Navient Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Navient Corporation's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Navient Corporation shares in existence, roughly 40 shares are currently held short) or 0.0367% of the tradable shares (for every 100,000 tradable Navient Corporation shares, roughly 37 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Navient Corporation.
Find out more about how you can short Navient Corporation stock.
Dividend payout ratio: 13.65% of net profits
Recently Navient Corporation has paid out, on average, around 13.65% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.19% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Navient Corporation shareholders could enjoy a 3.19% return on their shares, in the form of dividend payments. In Navient Corporation's case, that would currently equate to about $0.64 per share.
While Navient Corporation's payout ratio might seem low, this can signify that Navient Corporation is investing more in its future growth.
Navient Corporation's most recent dividend payout was on 16 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 1 September 2021 (the "ex-dividend date").
Over the last 12 months, Navient Corporation's shares have ranged in value from as little as $7.5438 up to $23.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Navient Corporation's is 1.8709. This would suggest that Navient Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Navient Corporation provides education loan management and business processing solutions for education, healthcare, and government clients at the federal, state, and local levels in the United States. It operates through four segments: Federal Education Loans, Consumer Lending, Business Processing, and Other. The company owns Federal Family Education Loan Program loans that are insured or guaranteed by state or not-for-profit agencies; and performs servicing and asset recovery services on its own loan portfolio, and federal education loans owned by the United States Department of Education and other institutions. It also owns, originates, and acquires private education loans; and offers healthcare services that include revenue cycle outsourcing, accounts receivable management, extended business office support, consulting engagement, and public health programs, as well as business processing services to state governments, agencies, court systems, municipalities, and parking and tolling authorities. In addition, the company provides customizable solutions for its clients that include hospitals, hospital systems, medical centers, large physician groups, other healthcare providers, and departments of public health; and corporate liquidity portfolio and debt repurchase services. Navient Corporation was founded in 1973 and is headquartered in Wilmington, Delaware. .
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.